UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1676
Peoples Bancorp
PEBO
$1.32B
| $2.39M | ﹤0.01% |
79,797
-38,088
| -32% | -$1.15M |
2020 Q2
21 quarters
|
|
1677
Ultra Clean Holdings
UCTT
$2.36B
| $2.39M | ﹤0.01% |
87,782
-43,474
| -33% | -$1.07M |
2018 Q1
30 quarters
|
|
1678
Vera Therapeutics
VERA
$2.03B
| $2.39M | ﹤0.01% |
82,282
-70,816
| -46% | -$1.64M |
2023 Q4
7 quarters
|
|
1679
Skyward Specialty Insurance
SKWD
$2.7B
| $2.37M | ﹤0.01% |
49,834
-82,752
| -62% | -$4.14M |
2024 Q2
5 quarters
|
|
1680
DELISTED
American Woodmark
AMWD
| $2.37M | ﹤0.01% |
35,434
-25,688
| -42% | -$1.58M |
2023 Q1
10 quarters
|
|
1681
US Physical Therapy
USPH
$1.27B
| $2.36M | ﹤0.01% |
27,780
-18,606
| -40% | -$1.49M |
2017 Q4
31 quarters
|
|
1682
Ocular Therapeutix
OCUL
$1.54B
| $2.35M | ﹤0.01% |
201,259
-115,017
| -36% | -$1.38M |
2024 Q2
5 quarters
|
|
1683
Amneal Pharmaceuticals
AMRX
$6.64B
| $2.34M | ﹤0.01% |
233,895
-236,537
| -50% | -$2.12M |
2024 Q1
6 quarters
|
|
1684
National Bank Holdings
NBHC
$1.68B
| $2.33M | ﹤0.01% |
60,416
-61,037
| -50% | -$2.37M |
2023 Q1
10 quarters
|
|
1685
Cable One
CABO
$43.2M
| $2.33M | ﹤0.01% |
13,149
-8,058
| -38% | -$1.21M |
2015 Q3
40 quarters
|
|
1686
Douglas Dynamics
PLOW
$911M
| $2.32M | ﹤0.01% |
74,372
-35,917
| -33% | -$1.12M |
2013 Q2
49 quarters
|
|
1687
Amer Sports
AS
$17.4B
| $2.32M | ﹤0.01% |
66,635
| – | – |
2025 Q2
1 quarter
|
|
1688
Winnebago Industries
WGO
$686M
| $2.32M | ﹤0.01% |
69,233
-45,436
| -40% | -$1.5M |
2017 Q2
33 quarters
|
|
1689
DELISTED
Stellar Bancorp
STEL
| $2.31M | ﹤0.01% |
76,222
-61,211
| -45% | -$1.86M |
2021 Q4
15 quarters
|
|
1690
Dime Commercial Bancshares
DCOM
$1.71B
| $2.31M | ﹤0.01% |
77,509
-42,037
| -35% | -$1.23M |
2021 Q2
17 quarters
|
|
1691
Canadian Imperial Bank of Commerce
CM
$102B
| $2.3M | ﹤0.01% |
28,766
-950,327
| -97% | -$71.5M |
2024 Q2
5 quarters
|
|
1692
DELISTED
AvalonBay Communities
AVB
| $2.29M | ﹤0.01% |
11,876
-184,673
| -94% | -$36M |
2023 Q1
10 quarters
|
|
1693
Icon
ICLR
$13B
| $2.28M | ﹤0.01% |
13,042
-15,012
| -54% | -$2.51M |
2020 Q2
21 quarters
|
|
1694
DELISTED
Treehouse Foods
THS
| $2.28M | ﹤0.01% |
112,891
-72,787
| -39% | -$1.38M |
2013 Q2
49 quarters
|
|
1695
Ubiquiti
UI
$36.4B
| $2.27M | ﹤0.01% |
3,443
-261
| -7% | -$130K |
2013 Q4
47 quarters
|
|
1696
Hudson Pacific Properties
HPP
$563M
| $2.27M | ﹤0.01% |
+117,705
| New | +$2.22M |
2025 Q3
0 quarters
|
|
1697
DELISTED
Heidrick & Struggles
HSII
| $2.27M | ﹤0.01% |
45,541
-26,323
| -37% | -$1.27M |
2020 Q4
19 quarters
|
|
1698
Turning Point Brands
TPB
$1.27B
| $2.26M | ﹤0.01% |
22,839
-19,812
| -46% | -$1.79M |
2024 Q2
5 quarters
|
|
1699
Carter's
CRI
$1.16B
| $2.26M | ﹤0.01% |
79,967
-45,063
| -36% | -$1.29M |
2013 Q2
49 quarters
|
|
1700
Edgewise Therapeutics
EWTX
$4.03B
| $2.26M | ﹤0.01% |
139,112
-52,494
| -27% | -$745K |
2023 Q4
7 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.